Canada wants to be at ‘front of line’ for coronavirus vaccines, signs deals with Novavax and Johnson & Johnson
Canada’s Prime Minister Trudeau visits the National Research Council of Canada in Montreal
By Steve Scherer
OTTAWA (Reuters) – Canada reached an agreement in principle on Monday with both Novavax Inc and Johnson & Johnson for millions of doses of their experimental coronavirus vaccines, Prime Minister Justin Trudeau said.
Canada’s two agreements follow separate deals with Pfizer Inc and Moderna Inc announced weeks ago, and are the latest example of countries rushing to secure access to vaccines.
Canada is also in “the final stages of negotiations” to secure AstraZeneca’s potential vaccine and is in talks to secure more doses of the Pfizer vaccine candidate, Procurement Minister Anita Anand said.- ADVERTISEMENT -https://s.yimg.com/rq/darla/3-28-0/html/r-sf-flx.html
“What we are trying to do is make sure that when a vaccine is developed, we are at the front of the line,” Anand told reporters.
Canada has a population of about 38 million, and the four vaccine agreements signed so far “give Canada at least 88 million doses with options to obtain tens of millions more,” Trudeau said when he announced the deals in Montreal.
All four agreements announced so far have options to purchase further doses if needed, officials said.
Trudeau also said the government will invest C$126 million ($96.7 million) over two years to build a biomanufacturing facility at the Human Health Therapeutics Research Centre in Montreal capable of producing up to 2 million doses of a vaccine per month by next year.
Last week, Canada’s National Research Council said it had ended its partnership on a coronavirus vaccine with China’s CanSino Biologics because the company lacked the authority to ship the vaccine.
Separately, Canada extended to the end of October a program to provide loans of up to C$40,000, a quarter of which is forgivable, to small businesses struggling amid the pandemic. It had been due to expire on Monday.
Novavax said it expects to finalize an advance purchase agreement to supply doses of the vaccine, beginning as early as the second quarter of next year.
The best of the Muslim Times’ collection for war against Covid 19:
In this day and age, understanding bacteria and viruses and developing vaccines are national security issues. In my view sizable part of every country’s defense budget should be spent in these pursuits rather than making tanks and other weapons.
For the latest news about drugs and vaccines’ trials please go to: Pharmaceutical-Technology
For the latest health news from BBC, Please click here
Novavax starting human trial of its vaccine in Australia
Kaiser Permanente launches first coronavirus vaccine trial
Corona Fear’s Cure: Chanting from the Bible and the Quran
Can You Chant from the Bible or the Quran to Bliss and Happiness?
Japanese flu drug ‘clearly effective’ in treating coronavirus, says China
Synthetic antibodies might offer a quick coronavirus treatment
The Four Possible Timelines for Life Returning to Normal
The Muslim Times Recommending Universal BCG Vaccination to Fight the Pandemic
Coronavirus: TB Vaccination Trial Started in Melbourne, Australia
The Muslim Times has the best collections in the war against Covid 19 as we are collecting from all the established sources
All of humanity are intimate neighbors: Coronavirus proves it once again
Praise be to God for the Miracle of Our Immune System
USA: 15-minute coronavirus test is here
Does the Ordinary Soap Kill Coronavirus?
Here’s a list of disinfectants you can use against coronavirus
For the number of cases and epidemiology in each country go to: WorldOMeters
DAILY NEW CASES AND DEATHS IN US, CDC SITE
Coronavirus Vaccine Tracker – The New York Times
Categories: Vaccine
Last week, Canada’s National Research Council said it had ended its partnership on a coronavirus vaccine with China’s CanSino Biologics because the company lacked the authority to ship the vaccine.
https://www.yahoo.com/news/novavax-signs-deal-supply-coronavirus-132057101.html
(Bloomberg) — Canada has agreed to buy more than 100 million Covid-19 vaccines from Novavax Inc. and Johnson & Johnson, Prime Minister Justin Trudeau said Monday.
The new agreements will guarantee as many as 76 million doses of NVX-CoV2373 from Gaithersburg, Maryland-based Novavax and 38 million doses of Ad26.COV2.S from New Brunswick, New Jersey-based Johnson & Johnson, Trudeau told reporters in Ottawa.
“It is possible that there is a breakthrough soon that will allow us to get a vaccine more quickly, but we don’t know where or if that breakthrough will come,” Trudeau said. “That’s why the government of Canada has moved forward on signing agreements with a broad range of vaccine developers.”
The deals for Covid-19 vaccines add to previously signed procurement agreements with Pfizer Inc., based in New York, for at least 20 million doses and Cambridge, Mass.-based Moderna Inc. for as many as 56 million doses.
Canada will “continue to negotiate and sign other agreements with a number of leading pharmaceutical companies, to ensure the supply of potential vaccines in Canada,” according to a statement from the Prime Minister’s Office. There are currently no vaccines approved to prevent Covid-19.
NVX-CoV2373 is currently in Phase 2 testing in countries including the U.S., Australia and South Africa. Novavax said it could provide the vaccine as early as June 2021.
“We are pleased to work with the Canadian government on supply of our COVID-19 vaccine, an essential step to ensure broad access of our vaccine candidate,” Stan Erck, chief executive officer at Novavax, said in a statement. “We are moving forward with clinical development of NVX-CoV2373 with a strong sense of urgency in our quest to deliver a vaccine to protect the world.”
https://finance.yahoo.com/news/trudeau-unveils-covid-19-vaccine-162844469.html
Reblogged this on Alexanders' Blog.